Michael Ho1, Amelie M Lutz2. 1. Institut für Diagnostische Radiologie, Universitätsklinikum Zürich, Rämistraße 100, 8091, Zürich, Schweiz. michael.ho@usz.ch. 2. Department of Radiology, Stanford University School of Medicine, 94305, Stanford, CA, USA.
Abstract
BACKGROUND: Differentiation between malignant and benign tumors of peripheral nerves in the early stages is challenging; however, due to the unfavorable prognosis of malignant tumors early identification is required. OBJECTIVES: To show the possibilities for detection, differential diagnosis and clinical management of peripheral nerve tumors by imaging appearance in magnetic resonance (MR) neurography. MATERIAL AND METHODS: Review of current literature available in PubMed and MEDLINE, supplemented by the authors' own observations in clinical practice. RESULTS: Although not pathognomonic, several imaging features have been reported for a differentiation between distinct peripheral nerve tumors. CONCLUSION: The use of MR neurography enables detection and initial differential diagnosis in tumors of peripheral nerves. Furthermore, it plays an important role in clinical follow-up, targeted biopsy and surgical planning.
BACKGROUND: Differentiation between malignant and benign tumors of peripheral nerves in the early stages is challenging; however, due to the unfavorable prognosis of malignant tumors early identification is required. OBJECTIVES: To show the possibilities for detection, differential diagnosis and clinical management of peripheral nerve tumors by imaging appearance in magnetic resonance (MR) neurography. MATERIAL AND METHODS: Review of current literature available in PubMed and MEDLINE, supplemented by the authors' own observations in clinical practice. RESULTS: Although not pathognomonic, several imaging features have been reported for a differentiation between distinct peripheral nerve tumors. CONCLUSION: The use of MR neurography enables detection and initial differential diagnosis in tumors of peripheral nerves. Furthermore, it plays an important role in clinical follow-up, targeted biopsy and surgical planning.
Authors: Michelle L Mauermann; Kimberly K Amrami; Nancy L Kuntz; Robert J Spinner; Peter J Dyck; E Peter Bosch; Janean Engelstad; Joel P Felmlee; P James B Dyck Journal: Brain Date: 2009-06-30 Impact factor: 13.501
Authors: M J L Descamps; L Barrett; M Groves; L Yung; R Birch; N M F Murray; D C Linch; M P T Lunn; M M Reilly Journal: J Neurol Neurosurg Psychiatry Date: 2006-09 Impact factor: 10.154
Authors: Changye Zou; Kerrington D Smith; Jun Liu; Guy Lahat; Sarah Myers; Wei-Lien Wang; Wei Zhang; Ian E McCutcheon; John M Slopis; Alexander J Lazar; Raphael E Pollock; Dina Lev Journal: Ann Surg Date: 2009-06 Impact factor: 12.969